Abstract:Purpose Agency theory postulates that research and development (R&D) investments are subject to managerial discretion and thus may not enhance firm value as expected. The inconclusive empirical findings in the literature is a testament of that. This paper aims to investigate the interplay between board gender diversity (i.e. women on boards) and value relevance of firms' effort to innovate as indicated by firms' R&D investments. Design/methodology/approach Through a sample of 1,626 US-listed firms from the period 2004 to 2019, the authors examine whether board gender diversity promotes or hampers value relevance of firms' efforts to innovate. The authors use ordinary least squares as the baseline model and address potential endogeneity through instrumental variable two-stage least square, and selection bias through Heckman selection model. Finally, the authors use the financial crisis of 2008 as a natural experiment to investigate the effect of board gender diversity during the crisis period. Findings The results show that board gender diversity positively moderates the relation between R&D and firm value. In times of financial crisis, R&D does not destroy firm value in firms with gender diverse board. The results are robust to measurement error, endogeneity issue, particularly simultaneity and selection bias. Practical implications The findings in this study have several practical implications. Firms that invest heavily in R&D should be mindful of gender diversity in their board recruitment strategies to enhance innovation outputs and firm value. Current and potential investors (i.e. shareholders) should take into consideration board gender diversity in their investment decision-making processes as the results show that gender diverse boards promote more effective governance, which, in turn, leads to better alignment of R&D investments with shareholder value. Regulators aiming to improve corporate governance policies should encourage gender diversity on the boards. The results align with global initiatives such as the United Nations Sustainable Development Goals, particularly Goal 5 on gender equality. Policymakers may use the findings in this study to advocate for more gender diverse governance structures within corporations. Originality/value This study investigates the role gender diverse boards play in creating value from firms' R&D activities.

Do diverse and inclusive workplaces benefit investors? An Empirical Analysis on Europe and the United States

How do ESG controversies moderate the nexus between ESG performance and cost of capital? Evidence from European listed companies

When R&D investment improves firm value: the role of board gender diversity

Does top executive gender diversity matter for the value relevance of ESG controversies? Empirical evidence from European tech firms

THE INFLUENCE OF GENDER DIVERSITY ON MARKET VALUE: A COMPARATIVE STUDY BETWEEN EUROPEAN AND LATIN AMERICAN COMPANIES

Do Investors Care about Biodiversity?

Workplace diversity and innovation performance: current state of affairs and future directions

Board Diversity, Firm Risk, and Corporate Policies

Employee demographic diversity and firm performance

Diversity of Institutional Investors' Bidding Opinions in Shaping the Sustainability of IPO Performance

International diversification and European firm value: the role of operating efficiency

Investors Embrace Gender Diversity, Not Female CEOs: The Role of Gender in Startup Fundraising

How Prior Realized Outcomes Affect Portfolio Decisions

Diversity and inclusion: Evidence from corporate inventors

The Relationship Between Shareholder Wealth Effects, Diversity, and Publicity as a Marketing Strategy

Study on the Impact of Diversity and Inclusion at Workplace

Board gender diversity and firm performance: new evidence from cultural diversity in the boardroom

Sustainability ratings and fund performance: New evidence from European ESG equity mutual funds

The Impact of ESG Factors on Asset Returns: Empirical Research

Institutional Investor Heterogeneity and Corporate Response to the Covid‐19 Pandemic

CEO GENDER AND FIRM PERFORMANCE: EVIDENCE FROM THE COVID-19 PANDEMIC